• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Astrana Health, Inc. Announces Share Repurchase of 300,000 Shares

    1/21/25 7:45:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary
    Get the next $ASTH alert in real time by email

    ALHAMBRA, Calif., Jan. 21, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that on January 17, 2025, the Company repurchased 300,000 shares of the Company's common stock for the aggregate purchase price of $10.551 million, based on a purchase price per share of $35.17, which was the closing price per share on the Nasdaq Stock Market on such date.

    Astrana Health Logo (PRNewsfoto/Astrana Health, Inc.)

    "The share repurchase is a testament to management and the Board of Directors' confidence in the performance of Astrana Health. We remain committed to our strategic capital deployment practices and continue to prioritize long-term growth, including through opportunistic share repurchases," said Brandon K. Sim, President and CEO of Astrana.

    The shares were purchased from Allied Physicians of California, a Professional Medical Corporation ("APC"), a long-standing stockholder and a consolidated affiliate of the Company. The Company's Board of Directors and the Audit Committee of the Board of Directors approved the repurchase.

    About Astrana Health, Inc.

    Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

    Headquartered in Alhambra, California, Astrana serves over 12,000 providers and over 1.1 million Americans in value-based care arrangements. Its subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), accountable care organizations (ACOs), and care delivery entities across primary, multi-specialty, and ancillary care. For more information, please visit www.astranahealth.com.

    FOR MORE INFORMATION, PLEASE CONTACT:

    Investor Relations

    (626) 943-6491

    Asher Dewhurst

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/astrana-health-inc-announces-share-repurchase-of-300-000-shares-302356096.html

    SOURCE Astrana Health, Inc.

    Get the next $ASTH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ASTH

    DatePrice TargetRatingAnalyst
    12/12/2025$28.00Buy
    Needham
    4/1/2025$36.00Equal Weight
    Barclays
    10/14/2024$66.00Buy
    TD Cowen
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    7/11/2024$44.00 → $50.00Hold → Buy
    Truist
    5/30/2024$54.00Outperform
    Robert W. Baird
    More analyst ratings

    $ASTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Needham initiated coverage on Astrana Health with a new price target

    Needham initiated coverage of Astrana Health with a rating of Buy and set a new price target of $28.00

    12/12/25 8:48:58 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Barclays initiated coverage on Astrana Health with a new price target

    Barclays initiated coverage of Astrana Health with a rating of Equal Weight and set a new price target of $36.00

    4/1/25 7:41:49 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    TD Cowen initiated coverage on Astrana Health with a new price target

    TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00

    10/14/24 7:24:49 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Astrana Health, Inc. to Participate in Upcoming Investor Conferences

    ALHAMBRA, Calif., April 10, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the following upcoming investor conferences: The 25th Annual Needham Virtual Healthcare Conference on April 13-16, 2026The Bank of America Global Healthcare Conference 2026, being held in Las Vegas on May 12-14, 2026

    4/10/26 8:00:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Foothill Regional Medical Center Receives 2026 Patient Safety Excellence Award™ from Healthgrades

    Recognition places Foothill Regional among the top 5% in the nation for patient safety TUSTIN, Calif., March 10, 2026 /PRNewswire/ -- Foothill Regional Medical Center, part of Astrana Health, Inc. (NASDAQ:ASTH), has been recognized as a 2026 Patient Safety Excellence Award™ recipient by Healthgrades, the nation's leading resource Americans use when searching for a hospital or doctor. Foothill Regional has received the Patient Safety Excellence Award™ four consecutive years (2023-2026). In addition to this patient safety recognition, Foothill Regional has earned several distingui

    3/11/26 8:00:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health, Inc. to Participate in Upcoming Investor Conferences

    ALHAMBRA, Calif., March 3, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced that leadership is participating in the following upcoming investor conferences: The TD Cowen 45th Annual Health Care Conference, being held in Boston on Wednesday, March 4, 2026, including a fireside chat at 9:10am ET.The Jefferies Value-Based Healthca

    3/3/26 5:00:00 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Basho Chandan

    4 - Astrana Health, Inc. (0001083446) (Issuer)

    4/15/26 4:15:37 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    SEC Form 4 filed by Lam Thomas S.

    4 - Astrana Health, Inc. (0001083446) (Issuer)

    4/8/26 4:43:38 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    SEC Form 4 filed by Sim Kenneth T.

    4 - Astrana Health, Inc. (0001083446) (Issuer)

    4/8/26 4:42:13 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    SEC Filings

    View All

    SEC Form DEFA14A filed by Astrana Health Inc.

    DEFA14A - Astrana Health, Inc. (0001083446) (Filer)

    4/17/26 6:02:12 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    SEC Form DEF 14A filed by Astrana Health Inc.

    DEF 14A - Astrana Health, Inc. (0001083446) (Filer)

    4/17/26 6:01:07 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    SEC Form S-3ASR filed by Astrana Health Inc.

    S-3ASR - Astrana Health, Inc. (0001083446) (Filer)

    3/30/26 7:39:07 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    $ASTH
    Financials

    Live finance-specific insights

    View All

    Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results

    Company to Host Conference Call on Monday, March 2, 2026, at 5:30 a.m. PT/8:30 a.m. ETReports total revenue for the year ended of $3,181.8 million, up 56% year-over-year, and at the higher end of guidanceReports adjusted EBITDA for the year ended of $205.4 million and free cash flow(1) of $104.5 millionALHAMBRA, Calif., March 2, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading physician-centric, technology-powered, risk-bearing healthcare management company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial result

    3/2/26 7:00:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health, Inc. Schedules 2025 Fourth Quarter and Year-End Financial Results Release and Conference Call

    ALHAMBRA, Calif., Jan. 26, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the fourth quarter and year ended December 31, 2025, before the open of the stock market on Monday, March 2, 2026. The Company will discuss those results on a conference call at 5:30 a.m. PT/8:30 a.m. ET that same day.

    1/26/26 8:00:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary

    Astrana Health, Inc. Reports Third Quarter 2025 Results

    Company to Host Conference Call on Thursday, November 6, 2025, at 2:30 p.m. PT/5:30 p.m. ET Reports total revenue of $956.0 million, up 100% year-over-year, and at the higher end of guidanceReports adjusted EBITDA of $68.5 million, at the higher end of guidanceCloses Prospect Health acquisition where standalone third quarter performance exceeded expectationsContinuing to control medical costs well; reiterating full-year trend expectationsUpdates full-year 2025 guidance to account for full-risk contract delays unrelated to core performanceALHAMBRA, Calif., Nov. 6, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (

    11/6/25 4:05:00 PM ET
    $ASTH
    Professional Services
    Consumer Discretionary